EP1451572A4 - Multidisziplinärer ansatz zur validierung oder identifizierung von zielmolekülen unter verwendung eines in-vivo-systems - Google Patents
Multidisziplinärer ansatz zur validierung oder identifizierung von zielmolekülen unter verwendung eines in-vivo-systemsInfo
- Publication number
- EP1451572A4 EP1451572A4 EP02804816A EP02804816A EP1451572A4 EP 1451572 A4 EP1451572 A4 EP 1451572A4 EP 02804816 A EP02804816 A EP 02804816A EP 02804816 A EP02804816 A EP 02804816A EP 1451572 A4 EP1451572 A4 EP 1451572A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- targets
- pathway
- vivo system
- validation
- identification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000010200 validation analysis Methods 0.000 title abstract 2
- 230000008236 biological pathway Effects 0.000 abstract 4
- 230000031018 biological processes and functions Effects 0.000 abstract 3
- 238000001727 in vivo Methods 0.000 abstract 3
- 239000000556 agonist Substances 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000004166 bioassay Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001476 gene delivery Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002493 microarray Methods 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/025—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a parvovirus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32642201P | 2001-10-03 | 2001-10-03 | |
| US326422P | 2001-10-03 | ||
| PCT/US2002/031554 WO2003063765A2 (en) | 2001-10-03 | 2002-10-03 | Multi-disciplinary approach to validating or identifying targets using an in vivo system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1451572A2 EP1451572A2 (de) | 2004-09-01 |
| EP1451572A4 true EP1451572A4 (de) | 2007-04-04 |
Family
ID=27662906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02804816A Withdrawn EP1451572A4 (de) | 2001-10-03 | 2002-10-03 | Multidisziplinärer ansatz zur validierung oder identifizierung von zielmolekülen unter verwendung eines in-vivo-systems |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1451572A4 (de) |
| CN (1) | CN1599866A (de) |
| AU (1) | AU2002365217A1 (de) |
| WO (1) | WO2003063765A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| EP4035659A1 (de) | 2016-11-29 | 2022-08-03 | PureTech LYT, Inc. | Exosome zur ausgabe von therapeutischen wirkstoffen |
| EP3583528A2 (de) * | 2017-02-15 | 2019-12-25 | Zymergen, Inc. | Prädiktionswerkzeug für bioreachables |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5919997A (en) * | 1993-11-18 | 1999-07-06 | Cold Spring Habor Labortary | Transgenic mice having modified cell-cycle regulation |
| US5917124A (en) * | 1997-09-12 | 1999-06-29 | Washington University | Transgenic mouse model of prostate cancer |
| ATE290596T1 (de) * | 1998-10-08 | 2005-03-15 | Univ Hong Kong | Verwendung transgener tiere, die eine mutation des collagen x enthalten |
-
2002
- 2002-10-03 CN CN 02824038 patent/CN1599866A/zh active Pending
- 2002-10-03 WO PCT/US2002/031554 patent/WO2003063765A2/en not_active Ceased
- 2002-10-03 EP EP02804816A patent/EP1451572A4/de not_active Withdrawn
- 2002-10-03 AU AU2002365217A patent/AU2002365217A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| No further relevant documents disclosed * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003063765A3 (en) | 2004-02-26 |
| EP1451572A2 (de) | 2004-09-01 |
| CN1599866A (zh) | 2005-03-23 |
| AU2002365217A1 (en) | 2003-09-02 |
| WO2003063765A2 (en) | 2003-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ahmed et al. | Single-cell RNA sequencing with spatial transcriptomics of cancer tissues | |
| Ryan et al. | MicroLESA: integrating autofluorescence microscopy, in situ micro-digestions, and liquid extraction surface analysis for high spatial resolution targeted proteomic studies | |
| Elkabti et al. | Caenorhabditis elegans as a model host to monitor the Candida infection processes | |
| Bodenmiller et al. | An integrated chemical, mass spectrometric and computational strategy for (quantitative) phosphoproteomics: application to Drosophila melanogaster Kc167 cells | |
| EP4363614B1 (de) | Einzelzellenprofilierung eines rna-translationsstatus | |
| EP4574992A3 (de) | Kombinatorisches dna-screening | |
| CN103134938A (zh) | 适体在蛋白质组学中的用途 | |
| Nguyen et al. | Single-cell mass spectrometry enables insight into heterogeneity in infectious disease | |
| Gangras et al. | Investigating SH-SY5Y neuroblastoma cell surfaceome as a model for neuronal-targeted novel therapeutic modalities | |
| Hurka et al. | Venomics of the Central European myrmicine ants Myrmica rubra and Myrmica ruginodis | |
| Hui et al. | Advances in spatial omics technologies | |
| Tian | Exploring intercellular signaling by proteomic approaches | |
| JP2014510919A (ja) | リガンドライブラリーを用いた診断および処置方法 | |
| Balinisteanu et al. | Cancer predisposition syndromes and thyroid cancer: keys for a short two-way street | |
| Levitsky et al. | Massive proteogenomic reanalysis of publicly available proteomic datasets of human tissues in search for protein recoding via adenosine-to-inosine RNA editing | |
| US11525164B2 (en) | Spatial metagenomic characterization of microbial biogeography | |
| Castillo et al. | Early effects of the soluble amyloid β25-35 peptide in rat cortical neurons: Modulation of signal transduction mediated by adenosine and group I metabotropic glutamate receptors | |
| Kummer et al. | Inflammasome in skeletal muscle: NLRP3 is an inflammatory cell stress component in inclusion body myositis | |
| Samiminemati et al. | Methods to investigate the secretome of senescent cells | |
| EP1451572A4 (de) | Multidisziplinärer ansatz zur validierung oder identifizierung von zielmolekülen unter verwendung eines in-vivo-systems | |
| DK1232260T3 (da) | Polymorfi i det humane MDR-1-gen og anvendelser deraf | |
| Ma et al. | Quantitative analysis of BDNF/TrkB protein and mRNA in cortical and striatal neurons using α‐tubulin as a normalization factor | |
| Geraldes et al. | The impact of single-cell genomics on the field of mycobacterial infection | |
| Shao et al. | A chemical approach for profiling intracellular AKT signaling dynamics from single cells | |
| Dihazi et al. | The secretome analysis of activated human renal fibroblasts revealed beneficial effect of the modulation of the secreted peptidyl-prolyl cis-trans isomerase A in kidney fibrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20040430 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20070307 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/86 20060101ALI20070301BHEP Ipc: A61K 48/00 20060101ALI20070301BHEP Ipc: A01K 67/027 20060101ALI20070301BHEP Ipc: A61K 31/70 20060101ALI20070301BHEP Ipc: A01N 43/04 20060101ALI20070301BHEP Ipc: A61K 49/00 20060101ALI20070301BHEP Ipc: G01N 33/00 20060101AFI20040513BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20080801 |